Healthcare & Medical Equipment Suppliers Sector Financials, Performance and Ratios
-
Sector Score
41.6 /100
Rank 8 out of 27 Sectors -
Advance/Decline
114/104
-
No. of Companies218
-
Avg. Market Cap9,895
-
Price to Earning Ratio34.53
-
Price to Earning Growth Ratio10.62
-
Price to Book Ratio48.15
-
Return on Equity37.93
-
Return on Capital Employed-
-
Return on Assets5.08
-
Dividend yield 1 year %0.19 %
-
Net Profit Growth Annual YoY %-2.30 %
-
Net Profit Growth Qtr YoY %20.89 %
-
Net Profit Growth Qtr QoQ %7.80 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Healthcare & Medical Equipment Suppliers Sector Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Healthcare & Medical Equipment Suppliers Peer comparison
Compare all stocks in Healthcare & Medical Equipment Suppliers industry listed on stock exchanges
| Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Agilent Tech |
|
47,899.7
|
169.9
|
L
 -1.8%
H
169.6
175
|
L
 -0.4%
H
169.6
177.5
|
L
 8.6%
H
157.1
177.5
|
L
 29.2%
H
125
177.5
|
L
 19.7%
H
108.4
177.5
|
L
 56.4%
H
96.4
177.5
|
L
 9.8%
H
96.4
177.5
|
L
 273.9%
H
42.9
179.6
|
| Amerisource Bergen Corp |
|
-
|
340
|
L
 -0.3%
H
336.5
342.2
|
L
 5.0%
H
323.6
345.5
|
L
 10.1%
H
295.0
345.5
|
L
 10.4%
H
295.0
345.5
|
L
 4.7%
H
244.8
377.5
|
L
 17.2%
H
244.8
377.5
|
L
 187.2%
H
113.7
377.5
|
L
 319.3%
H
68.4
377.5
|
| Abbott |
|
180,063.7
|
104.1
|
L
 -0.8%
H
103.5
104.9
|
L
 4.5%
H
99.8
105.9
|
L
 1.4%
H
95.1
105.9
|
L
 3.4%
H
95.1
117.3
|
L
 -19.0%
H
82.0
132.0
|
L
 8.9%
H
82.0
141.2
|
L
 -10.9%
H
82.0
142.6
|
L
 152.8%
H
37.4
142.6
|
| Alcon Inc - Registered Shares |
|
31,967.2
|
66.1
|
L
 -0.1%
H
65.4
66.2
|
L
 3.2%
H
62.1
67.0
|
L
 1.7%
H
62.1
67.0
|
L
 -5.9%
H
62.1
76.2
|
L
 -12.0%
H
61.8
87.6
|
L
 -9.6%
H
61.8
101.1
|
L
 -15.5%
H
55.2
101.1
|
L
H
39.4
101.1
|
| Artivion Inc |
|
1,086.3
|
22.3
|
L
 2.3%
H
21.5
22.5
|
L
 4.8%
H
21.1
22.5
|
L
 -4.6%
H
20.2
24.8
|
L
 -11.1%
H
20.2
30.1
|
L
 -47.1%
H
19.2
48.3
|
L
 69.8%
H
12.2
48.3
|
L
 7.7%
H
9.6
48.3
|
L
 31.1%
H
9.6
48.3
|
| Avantor Inc |
|
11,017.9
|
16.3
|
L
 -0.8%
H
16.2
16.6
|
L
 4.0%
H
15.4
16.6
|
L
 5.0%
H
14.6
16.6
|
L
 47.2%
H
10.2
16.6
|
L
 10.2%
H
7.3
16.6
|
L
 -21.7%
H
7.3
28
|
L
 -57.8%
H
7.3
42.5
|
L
H
6.7
44.4
|
| Baxter International |
|
12,919.7
|
25.0
|
L
 -1.2%
H
24.9
25.5
|
L
 2.6%
H
24.3
26.0
|
L
 9.6%
H
22.6
26.0
|
L
 10.5%
H
21.4
30
|
L
 8.2%
H
15.7
30
|
L
 -22.1%
H
15.7
44
|
L
 -68.0%
H
15.7
89.7
|
L
 -48.0%
H
15.7
95.2
|
| Becton, Dickinson and Co. |
|
51,955.1
|
190.7
|
L
 -0.5%
H
189.5
191.9
|
L
 3.8%
H
184.3
196.0
|
L
 5.4%
H
175.7
196.0
|
L
 20.6%
H
152.0
196.0
|
L
 0.9%
H
140.1
213.1
|
L
 -26.5%
H
140.1
262.2
|
L
 -18.0%
H
140.1
287.3
|
L
 13.1%
H
140.1
287.3
|
| Butterfly Network Inc (Class A) |
|
1,989.2
|
7.5
|
L
 3.0%
H
7.4
7.6
|
L
 -9.5%
H
7.2
8.6
|
L
 -5.2%
H
7.2
10.2
|
L
 12.8%
H
6.4
10.2
|
L
 252.4%
H
1.9
10.2
|
L
 822.2%
H
0.7
10.2
|
L
 -26.3%
H
0.7
11.0
|
L
H
0.7
29.1
|
| Bio-Rad Laboratories Inc (Class A) |
|
9,433.8
|
352.8
|
L
 -0.3%
H
350.6
356.3
|
L
 -3.6%
H
350.6
371.1
|
L
 -6.3%
H
350.6
390
|
L
 15.9%
H
285.4
396.2
|
L
 13.8%
H
236.7
396.2
|
L
 12.4%
H
211.4
396.2
|
L
 -51.5%
H
211.4
799.0
|
L
 117.3%
H
154.9
832.7
|
| Bausch + Lomb Corp |
|
5,932.5
|
16.6
|
L
 0.7%
H
16.3
16.8
|
L
 -4.0%
H
15.5
16.8
|
L
 -1.4%
H
15.5
17.5
|
L
 2.2%
H
15.5
18.5
|
L
 10.7%
H
14.4
18.9
|
L
 -2.3%
H
10.5
21.7
|
L
H
10.5
22.0
|
L
H
10.5
22.0
|
| Boston Scientific |
|
65,287.8
|
45.1
|
L
 1.5%
H
43.9
45.1
|
L
 5.4%
H
42.3
45.1
|
L
 4.0%
H
41.4
45.7
|
L
 2.3%
H
41.4
53.0
|
L
 -54.6%
H
41.4
105.7
|
L
 -11.2%
H
41.4
109.5
|
L
 5.3%
H
35.0
109.5
|
L
 94.9%
H
19.7
109.5
|
| Cardinal Health |
|
58,503.5
|
252.7
|
L
 -0.6%
H
249.5
254.5
|
L
 6.4%
H
233.9
255.6
|
L
 12.1%
H
216.7
255.6
|
L
 10.6%
H
216.7
258.3
|
L
 61.5%
H
155.8
258.3
|
L
 169.3%
H
90.2
258.3
|
L
 430.4%
H
45.9
258.3
|
L
 233.6%
H
39.1
258.3
|
| Conmed Corp |
|
1,379.3
|
46.1
|
L
 -1.4%
H
45.9
47.1
|
L
 3.7%
H
44.1
47.9
|
L
 1.4%
H
44.0
48.3
|
L
 6.6%
H
41.0
53.7
|
L
 1.9%
H
31.4
53.7
|
L
 -51.4%
H
31.4
117.3
|
L
 -67.4%
H
31.4
159.1
|
L
 14.1%
H
31.4
159.1
|
| Cooper Companies |
|
11,059.4
|
58.2
|
L
 0.4%
H
57.0
58.3
|
L
 7.0%
H
53.9
58.3
|
L
 5.2%
H
53.7
58.3
|
L
 -18.9%
H
51.0
78.1
|
L
 -19.2%
H
51.0
89.8
|
L
 -28.8%
H
51.0
112.4
|
L
 -41.4%
H
51.0
112.4
|
L
 28.8%
H
39.7
115.9
|
| Danaher |
|
157,771.2
|
224.4
|
L
 -2.0%
H
223.3
230.6
|
L
 2.1%
H
219.1
233.0
|
L
 6.0%
H
209.6
233.0
|
L
 10.1%
H
165.8
233.0
|
L
 7.4%
H
160.9
242.8
|
L
 9.6%
H
160.9
281.7
|
L
 -26.2%
H
160.9
331.7
|
L
 193.6%
H
76.2
334.0
|
| Enovis Corp |
|
1,145.9
|
19.9
|
L
 1.4%
H
19.4
20.2
|
L
 12.3%
H
17.4
20.2
|
L
 10.1%
H
16.7
20.2
|
L
 -26.6%
H
16.7
31.7
|
L
 -36.8%
H
16.7
34.3
|
L
 -59.0%
H
16.7
65.0
|
L
H
16.7
72.1
|
L
H
16.7
72.1
|
| Edwards Lifesciences |
|
50,273.6
|
87.2
|
L
 0.7%
H
86.6
87.7
|
L
 2.4%
H
84.6
88.4
|
L
 -1.2%
H
82.4
89.7
|
L
 1.7%
H
81.2
93.9
|
L
 16.9%
H
74.4
96.3
|
L
 25.1%
H
58.9
96.3
|
L
 -21.5%
H
58.9
131.7
|
L
 121.3%
H
27.0
131.7
|
| Glaukos Corp |
|
9,848.0
|
167.0
|
L
 1.3%
H
164.1
168.6
|
L
 0.8%
H
163.0
171.4
|
L
 1.9%
H
146.4
174.5
|
L
 6.5%
H
145.8
191.6
|
L
 91.5%
H
73.2
191.6
|
L
 146.9%
H
59.2
191.6
|
L
 268.0%
H
33.3
191.6
|
L
 373.4%
H
23.1
191.6
|
| Globus Medical Inc (Class A) |
|
10,216.9
|
75.7
|
L
 -1.4%
H
75.4
76.7
|
L
 1.3%
H
74.6
80.0
|
L
 2.1%
H
72.5
80.0
|
L
 -1.8%
H
72.5
88.9
|
L
 27.0%
H
59.5
101.4
|
L
 40.4%
H
43.4
101.4
|
L
 -0.9%
H
43.4
101.4
|
L
 226.6%
H
19.3
101.4
|
| Haemonetics Corp |
|
5,401.9
|
118.7
|
L
 0.4%
H
117
119.8
|
L
 0.0%
H
117
123.8
|
L
 9.5%
H
101.3
123.8
|
L
 52.5%
H
75.0
123.8
|
L
 136.2%
H
49.0
123.8
|
L
 30.8%
H
47.3
123.8
|
L
 77.0%
H
43.5
123.8
|
L
 244.4%
H
32.8
142.1
|
| Inspire Medical Systems Inc |
|
2,028.1
|
70.2
|
L
 2.0%
H
68.4
70.3
|
L
 1.8%
H
67.4
72.5
|
L
 -8.6%
H
66.1
77.3
|
L
 38.6%
H
48.2
78.8
|
L
 -10.1%
H
38.9
147.0
|
L
 -55.3%
H
38.9
257.4
|
L
 -71.7%
H
38.9
330
|
L
H
22.5
330
|
| Integer Holdings Corp |
|
4,309.1
|
126.8
|
L
 0.0%
H
126.7
126.8
|
L
 0.1%
H
126.5
126.8
|
L
 0.4%
H
126.2
126.8
|
L
 32.8%
H
94.9
126.8
|
L
 20.9%
H
62
126.8
|
L
 70.1%
H
62
146.4
|
L
 44.6%
H
50.1
146.4
|
L
 548.7%
H
18.1
146.4
|
| McKesson |
|
117,806.4
|
1,010.4
|
L
 0.6%
H
977.9
1012.6
|
L
 7.6%
H
936.8
1015.0
|
L
 15.5%
H
847.3
1015.0
|
L
 20.1%
H
808.6
1015.0
|
L
 28.6%
H
723.7
1015.0
|
L
 121.7%
H
431.4
1015.0
|
L
 403.2%
H
201.6
1015.0
|
L
 523.3%
H
106.1
1015.0
|
| Medtronic |
|
118,665.6
|
92.8
|
L
 -2.1%
H
92.7
94.8
|
L
 4.9%
H
90.2
96.5
|
L
 0.7%
H
85.2
96.5
|
L
 11.5%
H
81.5
96.5
|
L
 -3.1%
H
73.3
106.3
|
L
 27.6%
H
68.9
106.3
|
L
 -23.2%
H
68.9
124.8
|
L
 11.0%
H
68.9
135.9
|
| Mettler-Toledo International |
|
32,574.0
|
1,625.7
|
L
 0.2%
H
1620
1642
|
L
 4.9%
H
1549.8
1659.7
|
L
 16.8%
H
1396.1
1659.7
|
L
 24.1%
H
1216.9
1659.7
|
L
 20.5%
H
1023.1
1659.7
|
L
 61.0%
H
928.5
1659.7
|
L
 14.5%
H
928.5
1714.8
|
L
 296.5%
H
395.6
1714.8
|
| Envista Holdings Corp |
|
3,631.6
|
22.6
|
L
 -1.3%
H
22.6
23.0
|
L
 -1.7%
H
22.2
23.7
|
L
 -3.2%
H
22.2
24.5
|
L
 -15.5%
H
22.2
29
|
L
 13.3%
H
18.8
30.4
|
L
 -9.1%
H
14.2
30.4
|
L
 -41.1%
H
14.2
52.0
|
L
H
10.1
52.0
|
| Owens & Minor Inc |
|
16.9
|
0.2
|
L
 -8.3%
H
0.2
0.3
|
L
 -48.8%
H
0.2
0.4
|
L
 -75.3%
H
0.2
0.9
|
L
 -93.7%
H
0.2
3.6
|
L
 -95.4%
H
0.2
5.6
|
L
 -98.5%
H
0.2
28.4
|
L
 -99.3%
H
0.2
49.1
|
L
 -99.3%
H
0.2
49.2
|
| Penumbra Inc |
|
12,699.5
|
322.4
|
L
 0.5%
H
320.3
322.9
|
L
 0.9%
H
318.3
322.9
|
L
 1.5%
H
316.3
322.9
|
L
 1.3%
H
315.7
328.6
|
L
 29.5%
H
221.3
362.4
|
L
 55.9%
H
148
362.4
|
L
 21.3%
H
114.9
362.4
|
L
 338.7%
H
56.1
362.4
|
| Perkinelmer Inc |
|
-
|
150.9
|
L
 -1.1%
H
150.7
156.9
|
L
 -2.1%
H
148.8
158
|
L
 5.2%
H
140.1
166.3
|
L
 37.0%
H
102.4
166.3
|
L
 61.6%
H
81.2
166.3
|
L
 61.8%
H
81.2
166.3
|
L
 -11.4%
H
81.2
201.1
|
L
 187.6%
H
45.4
201.1
|
| Qiagen NV |
|
9,612.3
|
46.6
|
L
 0.9%
H
45.8
46.9
|
L
 2.6%
H
45.0
46.9
|
L
 7.4%
H
41.9
47.3
|
L
 13.1%
H
39.4
47.3
|
L
 -8.4%
H
32.5
57.8
|
L
 10.2%
H
32.5
57.8
|
L
 -20.0%
H
32.5
64.7
|
L
 53.3%
H
27.8
65.9
|
| ResMed |
|
33,721.1
|
239.8
|
L
 0.3%
H
235.5
240.3
|
L
 4.2%
H
230.1
242.6
|
L
 6.6%
H
218.0
242.6
|
L
 20.5%
H
190.2
242.6
|
L
 -10.6%
H
180.3
277.7
|
L
 68.3%
H
132.2
293.8
|
L
 -6.7%
H
132.2
293.8
|
L
 268.9%
H
56.6
301.3
|
| Silvergate Cap Corp (Class A) |
|
379.9
|
18.3
|
L
 0.9%
H
17.8
18.9
|
L
 0.7%
H
17.8
19
|
L
 0.5%
H
16.6
20.0
|
L
 -15.5%
H
16.6
24.6
|
L
 46%
H
10.9
24.6
|
L
 21.7%
H
10.9
24.6
|
L
 -88.5%
H
0.0
239.3
|
L
 3.5%
H
0.0
239.3
|
| Steris PLC |
|
21,642.1
|
222.0
|
L
 -0.3%
H
219.8
223.4
|
L
 3.5%
H
213.8
226.7
|
L
 8.3%
H
203.3
226.7
|
L
 1.9%
H
203.3
241.4
|
L
 -7.6%
H
195.1
269.4
|
L
 0.0%
H
195.1
269.4
|
L
 -0.6%
H
159.2
269.4
|
L
 220.3%
H
63.8
269.4
|
| Stevanato Grp Spa |
|
5,194.9
|
19.0
|
L
 0.6%
H
18.7
19.1
|
L
 -2.0%
H
18.5
19.8
|
L
 -12.4%
H
18.5
22.2
|
L
 -0.8%
H
18.5
23.3
|
L
 -22.2%
H
12.9
28.0
|
L
 -43.8%
H
12.9
34.7
|
L
 -20.3%
H
12.9
36.3
|
L
H
12.9
36.3
|
| Stryker |
|
114,281.8
|
297.9
|
L
 1.1%
H
290.0
301.2
|
L
 7.4%
H
274.5
301.2
|
L
 8.3%
H
268.7
301.2
|
L
 -6.9%
H
267
352.5
|
L
 -20.4%
H
267
392.6
|
L
 10.3%
H
255.7
406.2
|
L
 13.7%
H
188.8
406.2
|
L
 159.5%
H
106.5
406.2
|
| Smith & Nephew PLC (ADR) |
|
12,070.0
|
28.8
|
L
 -0.8%
H
28.7
29.0
|
L
 5.9%
H
27.2
29.4
|
L
 4.6%
H
26.1
29.4
|
L
 -5.7%
H
26.1
32.9
|
L
 -20.6%
H
26.1
37.5
|
L
 27.9%
H
21.5
38.8
|
L
 -17.0%
H
21.5
38.8
|
L
 -6.3%
H
21.5
52.3
|
| Teleflex Incorporated |
|
5,494.9
|
129.7
|
L
 -0.6%
H
129.2
131.5
|
L
 3.6%
H
123.0
131.5
|
L
 4.1%
H
118.3
131.5
|
L
 -3.7%
H
118.3
145
|
L
 1.2%
H
100.2
145
|
L
 -32.4%
H
100.2
257.9
|
L
 -64.0%
H
100.2
382.0
|
L
 -22.6%
H
100.2
449.4
|
| Thermo Fisher |
|
251,198.9
|
679.4
|
L
 -1.5%
H
673.5
693.0
|
L
 3.3%
H
652.5
704
|
L
 4.3%
H
635.3
704
|
L
 27.6%
H
495.0
704
|
L
 26.1%
H
435.3
704
|
L
 45.4%
H
385.5
704
|
L
 15.5%
H
385.5
704
|
L
 347.9%
H
139.1
704
|
| Waters |
|
42,666.2
|
434.3
|
L
 -0.6%
H
433.3
441.3
|
L
 0.1%
H
422.8
449.1
|
L
 3%
H
418
454.5
|
L
 17.7%
H
345.2
454.5
|
L
 29.8%
H
282.8
454.5
|
L
 74.7%
H
231.9
454.5
|
L
 24.9%
H
231.9
454.5
|
L
 177.1%
H
133.4
454.5
|
| West Pharma Services |
|
27,018.0
|
383.9
|
L
 0.0%
H
383.2
387.0
|
L
 4.9%
H
363.1
387.0
|
L
 6.0%
H
359.5
387.0
|
L
 7.2%
H
325.3
387.0
|
L
 41.9%
H
223.8
387.0
|
L
 2.4%
H
187.4
413.7
|
L
 -6.1%
H
187.4
475
|
L
 426.1%
H
70.2
475.4
|
| Zimmer Biomet Holdings |
|
18,118.2
|
95.0
|
L
 0.0%
H
93.9
95.5
|
L
 6.6%
H
89.2
95.9
|
L
 -0.4%
H
87.1
95.9
|
L
 4.3%
H
87.1
102.9
|
L
 -6.8%
H
79.1
106.9
|
L
 -10.5%
H
79.1
133.9
|
L
 -30.4%
H
79.1
149.3
|
L
 -21.8%
H
70.0
169.7
|
| BioRad Laboratories Inc |
|
10,483.5
|
364.2
|
L
H
364.2
364.2
|
L
 -0.3%
H
364.2
364.2
|
L
 -0.3%
H
364.2
364.2
|
L
 17.7%
H
337
365.1
|
L
 27.8%
H
244.5
365.1
|
L
 9.6%
H
225.3
373.4
|
L
 9.6%
H
225.3
373.4
|
L
 9.6%
H
225.3
373.4
|
| Revvity |
|
16,842.9
|
150.9
|
L
 -1.1%
H
150.7
156.9
|
L
 -2.1%
H
148.8
158
|
L
 5.2%
H
140.1
166.3
|
L
 37.0%
H
102.4
166.3
|
L
 61.6%
H
81.2
166.3
|
L
 48.6%
H
79.5
166.3
|
L
 -11.4%
H
79.5
203.2
|
L
 187.6%
H
45.4
203.2
|
| Aethlon Medical Inc |
|
3.7
|
5.2
|
L
 0.2%
H
4.9
5.2
|
L
 -14.7%
H
4.9
6.1
|
L
 -18.2%
H
4.9
7.2
|
L
 693.9%
H
0.5
9.5
|
L
 -5.0%
H
0.5
9.5
|
L
 -95.5%
H
0.5
188
|
L
 -99.8%
H
0.5
3176
|
L
 -100.0%
H
0.5
62041.2
|
| Airsculpt Tech Inc |
|
89.4
|
1.2
|
L
 -3.1%
H
1.2
1.3
|
L
 -23.5%
H
1.2
1.7
|
L
 -46.3%
H
1.2
2.5
|
L
 -72.1%
H
1.2
5.2
|
L
 -86.4%
H
1.2
12
|
L
 -81.7%
H
1.2
12
|
L
H
1.2
18.5
|
L
H
1.2
18.5
|
| Align Tech |
|
10,584.9
|
149
|
L
 1.2%
H
145.4
149.9
|
L
 4.4%
H
139.8
152.3
|
L
 0.9%
H
138.1
154.1
|
L
 -15.7%
H
138.1
188.0
|
L
 14.2%
H
130.2
200.4
|
L
 -45.3%
H
122
335.2
|
L
 -75.0%
H
122
713.3
|
L
 64.8%
H
83.3
737.5
|
| Angiodynamic Inc |
|
479.0
|
11.4
|
L
 1.3%
H
11.1
11.6
|
L
 -1.1%
H
10.6
11.7
|
L
 -26.2%
H
10.6
15.9
|
L
 -15.7%
H
10.6
16.3
|
L
 -1.3%
H
9.4
16.3
|
L
 64.1%
H
5.3
16.3
|
L
 -58.2%
H
5.3
32
|
L
 -32.7%
H
5.3
32
|
| Anika Therapeutics Inc |
|
270.6
|
20.2
|
L
 1.2%
H
19.9
20.5
|
L
 3.3%
H
19.3
20.9
|
L
 -2.8%
H
18.1
21.1
|
L
 32.6%
H
14.6
22.9
|
L
 120.5%
H
9.0
22.9
|
L
 5.0%
H
7.9
29.1
|
L
 -50.7%
H
7.9
45.8
|
L
 -55.0%
H
7.9
75.7
|
| Anzu Special Acq Corp I (Class A) |
|
-
|
0.7
|
L
 -3.0%
H
0.6
0.7
|
L
 -1.5%
H
0.6
0.7
|
L
 -8.5%
H
0.6
0.7
|
L
 -7.1%
H
0.6
0.8
|
L
 -22.6%
H
0.4
1.0
|
L
 -61.3%
H
0.4
1.9
|
L
 -93.3%
H
0.4
11.7
|
L
H
0.4
11.7
|
| Apyx Medical Corp |
|
101.9
|
2.4
|
L
 -5.1%
H
2.4
2.6
|
L
 -6.6%
H
2.4
2.7
|
L
 -20.9%
H
2.3
3.1
|
L
 -43.5%
H
2.3
4.4
|
L
 -17.1%
H
2.3
5.1
|
L
 7.1%
H
0.8
5.1
|
L
 -81.7%
H
0.8
17.5
|
L
 -48.2%
H
0.8
17.5
|
| Accuray Inc |
|
16.7
|
0.1
|
L
 -12.5%
H
0.1
0.2
|
L
 -39.1%
H
0.1
0.2
|
L
 -39.1%
H
0.1
0.4
|
L
 -46.2%
H
0.1
0.4
|
L
 -91.7%
H
0.1
1.8
|
L
 -95.0%
H
0.1
3.1
|
L
 -96.3%
H
0.1
5.9
|
L
 -97.5%
H
0.1
6.2
|
| Alphatec Holdings Inc |
|
1,607.8
|
10.4
|
L
 -0.5%
H
10.4
10.5
|
L
 -2.4%
H
10.3
11.5
|
L
 2.3%
H
9.7
11.5
|
L
 21.9%
H
8.0
11.5
|
L
 -30.1%
H
6.8
23.3
|
L
 -11.9%
H
4.9
23.3
|
L
 -12.5%
H
4.9
23.3
|
L
 55.6%
H
1.2
23.3
|
| Atricure Inc |
|
2,824.6
|
55.5
|
L
 -1.0%
H
55.2
56.6
|
L
 -0.5%
H
55.2
58.4
|
L
 -4.4%
H
51.6
61.7
|
L
 58.9%
H
31.9
61.7
|
L
 49.4%
H
25.4
61.7
|
L
 54.8%
H
18.9
61.7
|
L
 -22.0%
H
18.9
89.2
|
L
 226.8%
H
14.8
89.2
|
| Axogen Inc |
|
2,067.6
|
35.2
|
L
 1.8%
H
34.1
35.3
|
L
 -2.5%
H
34.1
37.4
|
L
 -20.3%
H
34.1
47
|
L
 -11.6%
H
34.1
52.9
|
L
 112.4%
H
16.7
52.9
|
L
 729.2%
H
3.5
52.9
|
L
 156.3%
H
3.5
52.9
|
L
 302.7%
H
3.5
56.9
|
| Axonics Inc |
|
25.0
|
0.5
|
L
 4.3%
H
0.5
0.5
|
L
 -49.0%
H
0.5
0.8
|
L
 -49.0%
H
0.5
0.8
|
L
 -49.0%
H
0.5
0.8
|
L
 -49.0%
H
0.5
0.8
|
L
 -99.1%
H
0.5
71.1
|
L
 -99.3%
H
0.5
79.9
|
L
H
0.5
79.9
|
| Bone Biologics Corp |
|
1.1
|
0.4
|
L
 2.5%
H
0.4
0.4
|
L
 -12.8%
H
0.4
0.5
|
L
 -21.2%
H
0.4
0.6
|
L
 -65.0%
H
0.4
1.2
|
L
 -83.5%
H
0.4
2.6
|
L
 -98.6%
H
0.4
63.4
|
L
 -100.0%
H
0.4
10255.5
|
L
 -100.0%
H
0.4
169920
|
| BioAffinity Tech Inc |
|
4.5
|
3.5
|
L
 -5.9%
H
3.4
3.7
|
L
 -25.6%
H
3.2
4.8
|
L
 -62.8%
H
3.2
9.4
|
L
 -66.8%
H
3.2
20.4
|
L
 -92.0%
H
3.2
80.7
|
L
 -99.4%
H
3.2
1629
|
L
H
3.2
6997.5
|
L
H
3.2
6997.5
|
| Bluejay Diagnostics Inc |
|
0.7
|
0.7
|
L
 -5.4%
H
0.7
0.7
|
L
 -14.6%
H
0.7
0.8
|
L
 -23.9%
H
0.7
1.0
|
L
 -51.7%
H
0.7
1.7
|
L
 -93.2%
H
0.7
10.7
|
L
 -100.0%
H
0.7
7792
|
L
H
0.7
200000
|
L
H
0.7
200000
|
| Biomerica Inc |
|
8.1
|
1.8
|
L
 -4.9%
H
1.8
1.9
|
L
 -4.4%
H
1.8
2.0
|
L
 -29.9%
H
1.8
2.8
|
L
 9.3%
H
1.5
2.8
|
L
 -40.9%
H
1.5
3.2
|
L
 128.6%
H
0.2
4.9
|
L
 -69.0%
H
0.2
6.1
|
L
 -32.8%
H
0.2
23.4
|
| Bruker Corp |
|
8,436.1
|
55.4
|
L
 1.0%
H
54.7
56.2
|
L
 -5.9%
H
54.3
58.8
|
L
 -9.7%
H
54.3
67.0
|
L
 -4.9%
H
48.6
67.0
|
L
 49.7%
H
32.4
67.0
|
L
 -8.0%
H
28.5
94.9
|
L
 -28.6%
H
28.5
94.9
|
L
 155.5%
H
19.6
94.9
|
| BioRestorative Therapies Inc |
|
2.2
|
1.6
|
L
 3.9%
H
1.5
1.7
|
L
 -16.2%
H
1.3
1.9
|
L
 -40.5%
H
1.3
2.9
|
L
 -76.1%
H
1.3
7
|
L
 -95.0%
H
1.3
34.4
|
L
 -95.7%
H
1.3
73.4
|
L
 -99.6%
H
1.3
395.8
|
L
 -100.0%
H
1.3
400800
|
| Bioventus Inc (Class A) |
|
921.4
|
13.5
|
L
 1.4%
H
13.2
13.5
|
L
 3.3%
H
13.0
14
|
L
 4.5%
H
12.5
14.2
|
L
 11.9%
H
11.4
15.9
|
L
 102.6%
H
6.5
15.9
|
L
 349.7%
H
3.0
15.9
|
L
 -2.6%
H
0.8
17.5
|
L
H
0.8
19.9
|
| Brainsway Ltd (ADR) |
|
482.6
|
12.0
|
L
 4.8%
H
11.8
12.2
|
L
 1.9%
H
11.3
12.2
|
L
 -11.9%
H
11.3
14.4
|
L
 -23.8%
H
11.3
17.4
|
L
 199.8%
H
3.6
17.4
|
L
 1262.5%
H
0.8
17.4
|
L
 508.6%
H
0.3
17.4
|
L
H
0.3
17.4
|
| Cardio Diagnostics Holdings Inc |
|
4.9
|
1.6
|
L
 -3.0%
H
1.6
1.7
|
L
 -12.3%
H
1.6
1.9
|
L
 -18.8%
H
1.6
2.2
|
L
 -4.7%
H
1.4
2.3
|
L
 -61.7%
H
1.0
7.9
|
L
 -78.3%
H
1.0
106.8
|
L
H
1.0
307.5
|
L
H
1.0
307.5
|
| Caredx Inc |
|
3,470.3
|
67.1
|
L
 4.8%
H
64.6
68.1
|
L
 5.4%
H
61.3
68.2
|
L
 24.6%
H
53.5
72.5
|
L
 68.8%
H
35.0
72.5
|
L
 365.5%
H
14.0
72.5
|
L
 1093.6%
H
4.8
72.5
|
L
 -5.5%
H
4.8
75.9
|
L
 1572.8%
H
0.8
99.8
|
| Celcuity Inc |
|
2,795.0
|
57.1
|
L
 1.0%
H
56.6
59.5
|
L
 -15.9%
H
53.5
67.5
|
L
 -29.1%
H
53.5
88.7
|
L
 -35.4%
H
53.5
98
|
L
 9.9%
H
53.5
151.0
|
L
 489.5%
H
7.6
151.0
|
L
 223.8%
H
4.8
151.0
|
L
H
4.0
151.0
|
| Creative Medical Tech Holdings Inc |
|
5.5
|
0.7
|
L
 -2.7%
H
0.7
0.8
|
L
 -14.3%
H
0.7
0.9
|
L
 -25.8%
H
0.7
1.1
|
L
 -18.2%
H
0.6
1.9
|
L
 -79.9%
H
0.6
6.3
|
L
 -84.8%
H
0.6
10.3
|
L
 -99.1%
H
0.6
90
|
L
 -100.0%
H
0.6
525000
|
| Cerus Corp |
|
447.4
|
2.2
|
L
 1.8%
H
2.1
2.2
|
L
 -3.5%
H
2.1
2.3
|
L
 -16.2%
H
2.1
2.7
|
L
 -29.1%
H
2.1
3.2
|
L
 45.1%
H
1.4
3.5
|
L
 72.1%
H
1.1
3.5
|
L
 -63.5%
H
1.1
8.1
|
L
 -57.8%
H
1.1
8.9
|
| Check-Cap Ltd |
|
34.6
|
2.3
|
L
 -17.8%
H
2.2
2.6
|
L
 -30.7%
H
2.2
3.4
|
L
 -64.6%
H
2.2
6.8
|
L
 -67.7%
H
1.2
10.5
|
L
 -82.3%
H
1.2
27.4
|
L
 -90.3%
H
1.2
27.6
|
L
 -98.1%
H
1.2
183.4
|
L
 -99.9%
H
1.2
4956
|
| Ridgetech Inc |
|
3.0
|
0.8
|
L
 -1.2%
H
0.8
0.9
|
L
 -17.8%
H
0.8
1.0
|
L
 -8.8%
H
0.8
1.3
|
L
 -41.1%
H
0.7
1.8
|
L
 -99.7%
H
0.7
760.5
|
L
 -99.9%
H
0.7
760.5
|
L
 -100.0%
H
0.7
35370
|
L
 -100.0%
H
0.7
124560
|
| CollPlant biotech Ltd - Ordinary Shares New |
|
5.1
|
3.6
|
L
 -1.7%
H
3.5
3.7
|
L
 1.4%
H
3.5
4.5
|
L
 -21.9%
H
3.3
4.6
|
L
 6.3%
H
2.6
9.6
|
L
 -84.7%
H
2.6
26.8
|
L
 -93.1%
H
2.6
69.9
|
L
 -97.8%
H
2.6
230
|
L
 -98.0%
H
2.6
242.6
|
| ClearPoint Neuro Inc |
|
279.7
|
9.2
|
L
 1.1%
H
9.0
9.2
|
L
 -12.5%
H
9.0
10.5
|
L
 -33.7%
H
9.0
16.5
|
L
 -39.5%
H
9.0
17.2
|
L
 -63.9%
H
8.3
28.1
|
L
 84.9%
H
4.1
30.1
|
L
 -46.7%
H
4.1
30.1
|
L
 110.8%
H
1.3
31.3
|
| Cardiff Oncology Inc |
|
69.2
|
0.9
|
L
 -1.1%
H
0.9
0.9
|
L
 -17.6%
H
0.9
1.1
|
L
 -35.0%
H
0.9
1.4
|
L
 1.1%
H
0.8
1.5
|
L
 -59.4%
H
0.8
3.3
|
L
 -23.3%
H
0.8
6.4
|
L
 -85.6%
H
0.8
7.3
|
L
 -99.7%
H
0.7
309.6
|
| Castle Biosciences Inc |
|
982.5
|
32.2
|
L
 0.6%
H
31.7
32.7
|
L
 -6.6%
H
31.7
34.4
|
L
 -9%
H
31.7
38.0
|
L
 33.1%
H
23.3
38.0
|
L
 45.3%
H
17.7
44.3
|
L
 147.0%
H
12.2
44.3
|
L
 -48.7%
H
9.3
68.7
|
L
H
9.3
107.7
|
| Cytek BioSciences Inc |
|
682.4
|
5.3
|
L
H
5.2
5.3
|
L
 -3.3%
H
5.1
5.5
|
L
 -0.9%
H
5.0
6.2
|
L
 13.6%
H
4.0
6.2
|
L
 32.9%
H
3.3
6.2
|
L
 8.5%
H
2.4
9.9
|
L
 -77.8%
H
2.4
26.5
|
L
H
2.4
28.7
|
| Cytosorbents Corp |
|
15.6
|
5.0
|
L
 20.7%
H
4.1
5.3
|
L
 30.9%
H
2.8
5.3
|
L
 -13.7%
H
2.8
5.8
|
L
 -31.1%
H
2.8
9.4
|
L
 -72.0%
H
2.8
18
|
L
 -84.5%
H
2.8
42.8
|
L
 -95.8%
H
2.8
132.8
|
L
 -95.5%
H
2.8
299
|
| Citius Pharma Inc |
|
11.8
|
0.4
|
L
 -6.5%
H
0.4
0.5
|
L
 -14%
H
0.4
0.5
|
L
 -28.3%
H
0.4
0.6
|
L
 -14%
H
0.4
0.8
|
L
 -70.3%
H
0.4
2.2
|
L
 -97.7%
H
0.1
26.8
|
L
 -99.2%
H
0.1
53.9
|
L
 -99.8%
H
0.1
371.3
|
| CVRx Inc |
|
36.0
|
1.4
|
L
 3.9%
H
1.3
1.4
|
L
 -14.6%
H
1.3
1.7
|
L
 -55.6%
H
1.3
3.1
|
L
 -72.5%
H
1.3
6
|
L
 -86.4%
H
1.3
11.3
|
L
 -90.1%
H
1.3
33.1
|
L
 -91.1%
H
1.3
33.1
|
L
H
1.3
33.1
|
| Delcath Systems Inc |
|
498.6
|
14.4
|
L
 2.1%
H
14.1
14.5
|
L
 -6.5%
H
14
15.8
|
L
 -10.8%
H
14
16.4
|
L
 12.2%
H
11.5
17.4
|
L
 20.1%
H
8.1
17.4
|
L
 278.2%
H
2.3
18.2
|
L
 49.5%
H
2.3
18.2
|
L
 -100.0%
H
2.3
400575000
|
| DarioHealth Corp |
|
44.0
|
4.5
|
L
 -6.9%
H
4.5
5.3
|
L
 -22.6%
H
4.5
6.4
|
L
 -37.6%
H
4.5
7.1
|
L
 -34.1%
H
4.5
8.2
|
L
 -65.5%
H
4.5
16.5
|
L
 -91.8%
H
4.5
56.6
|
L
 -98.5%
H
4.5
387.8
|
L
 -99.7%
H
4.5
1880
|
| Alpha Tau Medical Ltd |
|
1,167.1
|
12.6
|
L
 2.7%
H
12.4
12.8
|
L
 -12.4%
H
12.0
14.4
|
L
 -17.2%
H
12.0
15.6
|
L
 -6.9%
H
11.0
15.8
|
L
 236.5%
H
3.4
15.8
|
L
 252.5%
H
1.8
15.8
|
L
H
1.8
20.7
|
L
H
1.8
20.7
|
| DexCom |
|
32,445.5
|
86.0
|
L
 -0.1%
H
85.4
86.6
|
L
 2.2%
H
83.3
88.9
|
L
 -3.8%
H
82.9
90.4
|
L
 12.2%
H
69.8
92.6
|
L
 29.1%
H
54.1
92.6
|
L
 2.2%
H
54.1
142
|
L
 -36.5%
H
54.1
164.9
|
L
 316.8%
H
10.7
164.9
|
| ElectroCore Inc |
|
68.8
|
7.6
|
L
 -2.8%
H
7.4
8.2
|
L
 -21.0%
H
7.4
9.8
|
L
 -34.7%
H
7.4
12.7
|
L
 29.8%
H
5.7
12.7
|
L
 55.4%
H
4.4
12.7
|
L
 34.3%
H
4.2
19.5
|
L
 -48.1%
H
2.9
19.5
|
L
H
2.9
303.8
|
| ChronoScale Corp |
|
2,180.2
|
15.0
|
L
 -0.7%
H
14.9
15.7
|
L
 -19.5%
H
12.6
18.5
|
L
 -26.7%
H
12.6
22.6
|
L
 -43.4%
H
12.6
29.5
|
L
 224.7%
H
3.5
30
|
L
 -91.7%
H
2.7
704.0
|
L
 -98.4%
H
2.7
1010.3
|
L
 -99.9%
H
2.7
19912.5
|
| Embecta Corp |
|
351.9
|
6.2
|
L
 -1.0%
H
6.2
6.4
|
L
 9.3%
H
5.8
6.6
|
L
 17.4%
H
5.1
6.6
|
L
 91.1%
H
3.2
6.6
|
L
 -54.2%
H
2.8
14.9
|
L
 -59.7%
H
2.8
21.5
|
L
H
2.8
63
|
L
H
2.8
63
|
| Establishment Labs Holdings Inc |
|
1,736.3
|
58.3
|
L
 -1.6%
H
57.9
60.6
|
L
 -5.5%
H
55.1
63.8
|
L
 -15.9%
H
55.1
71.6
|
L
 -37.1%
H
55.1
97.6
|
L
 23.3%
H
47
97.6
|
L
 57.0%
H
17
97.6
|
L
 -24.4%
H
17
97.6
|
L
H
7.6
97.6
|
| EDAP TMS S.A. (ADR) |
|
152.6
|
4.1
|
L
 -0.5%
H
4.1
4.2
|
L
 -2.9%
H
4.0
4.4
|
L
 -1.9%
H
4.0
4.8
|
L
 -25.2%
H
4.0
6.4
|
L
 81.7%
H
1.8
6.4
|
L
 -39.3%
H
1.2
8.5
|
L
 -33.6%
H
1.2
12.7
|
L
 47.5%
H
1.2
12.7
|
| GlucoTrack Inc |
|
0.7
|
0.7
|
L
 -5.6%
H
0.7
0.7
|
L
 -34.0%
H
0.7
1.2
|
L
 -72.5%
H
0.7
3.3
|
L
 -90.8%
H
0.7
13.5
|
L
 -99.3%
H
0.7
112.5
|
L
 -100.0%
H
0.7
89100
|
L
 -100.0%
H
0.7
472500
|
L
 -100.0%
H
0.7
7020000
|
| GE HealthCare Tech |
|
31,509.6
|
69.8
|
L
 0.3%
H
69.1
70.1
|
L
 6.1%
H
65.7
71.3
|
L
 8.8%
H
63.3
71.3
|
L
 10.6%
H
60.2
75.7
|
L
 -5.8%
H
58.8
89.8
|
L
 6.9%
H
57.7
94.8
|
L
H
53
94.8
|
L
H
53
94.8
|
| Guardant Health Inc |
|
21,186.9
|
157.9
|
L
 -0.5%
H
155
163.9
|
L
 -5.7%
H
155
168.9
|
L
 -12.0%
H
155
191.1
|
L
 1.3%
H
140.9
191.1
|
L
 141.2%
H
66.0
191.1
|
L
 491.3%
H
15.8
191.1
|
L
 58.8%
H
15.8
191.1
|
L
H
15.8
191.1
|
| Harvard Bioscience Inc |
|
36.8
|
8.1
|
L
H
7.9
8.1
|
L
 -1.8%
H
7.9
8.5
|
L
 1.8%
H
7.9
8.8
|
L
 29.9%
H
5.9
8.8
|
L
 113.5%
H
3.8
9.4
|
L
 -80.8%
H
2.8
55.6
|
L
 -87.9%
H
2.8
82.3
|
L
 -68.9%
H
2.8
87.5
|
| Cue Health Inc |
|
4,352.8
|
27.4
|
L
 1%
H
27.1
27.6
|
L
 -4.7%
H
27.1
29.1
|
L
 -6.6%
H
27.1
31.7
|
L
H
24.9
31.7
|
L
H
24.9
31.7
|
L
 6740%
H
0
31.7
|
L
 175.0%
H
0
31.7
|
L
H
0
31.7
|
| Heart Test Laboratories Inc |
|
14.9
|
3.1
|
L
 1.7%
H
2.9
3.2
|
L
 -3.5%
H
2.9
3.4
|
L
 -41.0%
H
2.9
5.3
|
L
 14.1%
H
1.9
5.3
|
L
 -7.8%
H
1.6
5.3
|
L
 -91.8%
H
1.6
52
|
L
H
1.6
600
|
L
H
1.6
600
|
| Helius Medical Tech Inc (Class A) |
|
145.8
|
2.2
|
L
H
2.2
2.4
|
L
 -6.3%
H
2.2
2.5
|
L
 -18.8%
H
2.2
3.4
|
L
 33.3%
H
1.6
3.4
|
L
 -71.1%
H
1.2
7.2
|
L
 -100.0%
H
1.2
7125
|
L
 -100.0%
H
1.2
553312.5
|
L
 -100.0%
H
1.2
27168750
|
| Henry Schein |
|
9,358.2
|
84.0
|
L
 -2.8%
H
83.9
87.4
|
L
 -0.1%
H
83.9
88.1
|
L
 -1.0%
H
79.4
88.1
|
L
 -4.4%
H
79.4
92.2
|
L
 33.3%
H
62.1
92.2
|
L
 18.8%
H
60.0
92.2
|
L
 9.7%
H
60.0
92.7
|
L
 39.7%
H
41.9
92.7
|
| Hyperfine Inc (Class A) |
|
82.7
|
0.8
|
L
 2.6%
H
0.7
0.8
|
L
 -16.1%
H
0.7
0.9
|
L
H
0.7
1.1
|
L
 -16.1%
H
0.7
1.1
|
L
 -40%
H
0.7
1.9
|
L
 -58.7%
H
0.5
2.2
|
L
 -92.2%
H
0.5
16.6
|
L
H
0.5
16.6
|
| Integra Lifesciences Holdings Corp |
|
1,046.0
|
13.5
|
L
 1.8%
H
13.1
13.5
|
L
 0.1%
H
12.9
14.3
|
L
 -11.6%
H
12.4
16.8
|
L
 -30.1%
H
12.4
20.5
|
L
 -10.8%
H
8.7
20.5
|
L
 -65.4%
H
8.7
45.4
|
L
 -80.1%
H
8.7
75.0
|
L
 -67.1%
H
8.7
77.4
|
| Icecure Medical Ltd |
|
5.0
|
1.1
|
L
 1.9%
H
1.0
1.1
|
L
 -1.8%
H
1.0
1.2
|
L
 -44.9%
H
1.0
2.1
|
L
 -70.4%
H
1.0
3.6
|
L
 -95.6%
H
1.0
25.8
|
L
 -96.1%
H
1.0
49.8
|
L
 -99.4%
H
1.0
246.9
|
L
 -96.9%
H
1.0
480
|
| SeaStar Medical Holding Corp |
|
16.4
|
3.1
|
L
 7.2%
H
3.0
3.2
|
L
 -13.9%
H
2.8
4.0
|
L
 -12.2%
H
2.8
4.8
|
L
 -22.3%
H
2.8
4.8
|
L
 -94.9%
H
2.1
65
|
L
 -99.8%
H
2.1
4292.3
|
L
 -100.0%
H
2.1
55000
|
L
H
2.1
55000
|
| ICU Medical Inc |
|
4,032.1
|
161.2
|
L
 -1.1%
H
160.2
164.2
|
L
 0.6%
H
159.5
167.8
|
L
 5.6%
H
152.5
167.8
|
L
 2.4%
H
151.3
192.9
|
L
 36.1%
H
113.4
192.9
|
L
 45.7%
H
78.4
196.3
|
L
 -28.5%
H
78.4
251.8
|
L
 11.9%
H
78.4
321.7
|
| Idexx Laboratories |
|
43,786.5
|
555.8
|
L
 -0.8%
H
553.5
564.0
|
L
 7.3%
H
514.7
566.5
|
L
 8.6%
H
501.2
566.5
|
L
 -2.1%
H
500.6
624.2
|
L
 -12.5%
H
500.6
770.0
|
L
 30.7%
H
356.3
770.0
|
L
 -12.9%
H
317.1
770.0
|
L
 393.7%
H
102.5
770.0
|
| QTREX Quantum |
|
77.6
|
1.4
|
L
 -6.7%
H
1.4
1.5
|
L
 -25.1%
H
1.4
1.8
|
L
 59.1%
H
0.6
1.9
|
L
 10.2%
H
0.6
1.9
|
L
 27.3%
H
0.3
3.9
|
L
 8.5%
H
0.3
3.9
|
L
 -42.6%
H
0.3
9.6
|
L
H
0.3
9.6
|
| Illumina Inc |
|
39,661.7
|
262.7
|
L
 0.1%
H
260.2
270.9
|
L
 -5.6%
H
257.1
278
|
L
 9.6%
H
234.6
309.3
|
L
 40.7%
H
178.9
309.3
|
L
 175.2%
H
94
309.3
|
L
 111.1%
H
68.7
309.3
|
L
 -36.0%
H
68.7
428
|
L
 80.9%
H
68.7
555.8
|
| Intercure Ltd |
|
66.9
|
4.5
|
L
 -2.4%
H
4.5
4.5
|
L
 -13.7%
H
4.5
5.5
|
L
 -16.0%
H
4.5
5.7
|
L
 -2.6%
H
4.2
6.1
|
L
 -43.9%
H
3.4
7.9
|
L
 -24.4%
H
3.4
18.6
|
L
 -87.2%
H
3.4
43.9
|
L
H
3.4
96.8
|
| Inogen Inc |
|
173.8
|
6.6
|
L
 4.8%
H
6.3
6.6
|
L
 6.0%
H
6.1
6.6
|
L
 27.4%
H
5.0
6.6
|
L
 -0.3%
H
5.0
6.9
|
L
 -21.7%
H
5.0
9.1
|
L
 40.0%
H
4.1
13.3
|
L
 -84.1%
H
4.1
42.2
|
L
 -88.7%
H
4.1
287.8
|
| Inmode Ltd |
|
809.6
|
14.1
|
L
 -0.6%
H
14.1
14.3
|
L
 -1.0%
H
14.1
14.5
|
L
 -2.0%
H
13.9
14.6
|
L
 -9.1%
H
13.9
15.6
|
L
 -8.1%
H
12.7
16.7
|
L
 -32.2%
H
12.7
26.8
|
L
 -83.5%
H
12.7
99.3
|
L
H
6.5
99.3
|
| NAYA Biosciences |
|
1.5
|
0.6
|
L
 7.1%
H
0.6
0.6
|
L
 -17.8%
H
0.5
0.8
|
L
 -38.1%
H
0.5
1.0
|
L
 -42.3%
H
0.5
2.8
|
L
 -98.0%
H
0.5
30
|
L
 -99.9%
H
0.5
5040
|
L
 -100.0%
H
0.5
120960
|
L
 -100.0%
H
0.5
709632
|
| IRIDEX Corp |
|
13.5
|
0.8
|
L
 -6.1%
H
0.8
0.8
|
L
 -13.5%
H
0.8
1.0
|
L
 14.9%
H
0.6
1.0
|
L
 -17.2%
H
0.6
1.0
|
L
 -26.0%
H
0.6
1.7
|
L
 -74.2%
H
0.6
3.7
|
L
 -89.6%
H
0.6
9.5
|
L
 -94.0%
H
0.6
16.4
|
| Iradimed Corp |
|
1,120.8
|
87.7
|
L
 -0.7%
H
87.0
88.8
|
L
 0.2%
H
86.9
91.1
|
L
 6.7%
H
81.5
91.1
|
L
 -9.7%
H
81.4
98.5
|
L
 19.4%
H
73.2
107.9
|
L
 124.9%
H
37.5
107.9
|
L
 138.2%
H
26
107.9
|
L
 828.5%
H
7.9
107.9
|
| iRhythm Tech Inc |
|
3,612.7
|
109.6
|
L
 0.9%
H
107.9
110.8
|
L
 2.7%
H
104.5
113
|
L
 0.3%
H
100.7
117.0
|
L
 -1.2%
H
100.7
136.7
|
L
 -39.7%
H
100.7
212
|
L
 30.7%
H
55.9
212
|
L
 56.1%
H
55.9
212
|
L
H
22.2
286.2
|
| Intuitive Surgical |
|
155,198.9
|
433.2
|
L
 1.5%
H
426.7
434.6
|
L
 2.2%
H
414.7
434.9
|
L
 10.1%
H
389.1
434.9
|
L
 25.4%
H
328.6
434.9
|
L
 -2.9%
H
328.6
603.9
|
L
 57.2%
H
254.9
616
|
L
 30.4%
H
180.1
616
|
L
 440.2%
H
67.9
616
|
| Jowell Global Ltd |
|
4.9
|
2.1
|
L
 -2.8%
H
1.9
2.1
|
L
 -14.8%
H
1.9
2.5
|
L
 -8.8%
H
1.9
2.8
|
L
 2.0%
H
1.5
5.2
|
L
 22.4%
H
1.5
5.2
|
L
 -54.6%
H
1
5.2
|
L
 -97.7%
H
1
412.5
|
L
H
1
412.5
|
| Kewaunee Scientific Corp |
|
92.9
|
32.1
|
L
 -2.5%
H
32.1
32.5
|
L
 -5%
H
32.0
33.4
|
L
 -5.9%
H
32.0
35.3
|
L
 -15.8%
H
32
39
|
L
 -25.7%
H
32
46.6
|
L
 77.8%
H
16.5
71.3
|
L
 143.2%
H
12.1
71.3
|
L
 44.3%
H
7.0
71.3
|
| OrthoPediatrics corp |
|
575.2
|
22.0
|
L
 0.4%
H
21.9
22.3
|
L
 1.8%
H
21.6
23.1
|
L
 1.0%
H
21.3
23.1
|
L
 14.6%
H
18.1
26.7
|
L
 27.8%
H
14.4
26.7
|
L
 -13.5%
H
14.4
36.1
|
L
 -64.0%
H
14.4
73.9
|
L
H
14
73.9
|
| KORU Medical Systems Inc |
|
139.4
|
3.0
|
L
 0.7%
H
2.9
3.0
|
L
 2.0%
H
2.9
3.1
|
L
 -6.5%
H
2.9
3.4
|
L
 -26.5%
H
2.9
4.4
|
L
 -25.4%
H
2.9
6.6
|
L
 16.2%
H
1.9
6.6
|
L
 9.8%
H
1.8
6.6
|
L
 636.6%
H
0.3
12.8
|
| Standard BioTools Inc |
|
251.3
|
0.6
|
L
 1.6%
H
0.6
0.7
|
L
 -7.3%
H
0.6
0.7
|
L
 -16.9%
H
0.6
0.8
|
L
 -28.9%
H
0.6
0.9
|
L
 -49.6%
H
0.6
1.7
|
L
 -66.8%
H
0.6
3.0
|
L
 -87.9%
H
0.6
5.6
|
L
 -86.3%
H
0.6
14.9
|
| LivaNova PLC |
|
4,305.0
|
78.1
|
L
 0.7%
H
77.4
78.8
|
L
 2.3%
H
75.1
79.3
|
L
 0.2%
H
74.1
80.2
|
L
 -3.2%
H
74.1
85.8
|
L
 45.4%
H
48.8
85.8
|
L
 56.3%
H
32.5
85.8
|
L
 -5.1%
H
32.5
93.9
|
L
 37.4%
H
32.5
131.5
|
| Lemaitre Vascular Inc |
|
1,882.4
|
82.3
|
L
 1.8%
H
80.7
82.7
|
L
 2.0%
H
80.0
84.7
|
L
 4.4%
H
78.2
84.7
|
L
 -19.0%
H
78.2
106.3
|
L
 -5.0%
H
78.2
118.0
|
L
 70.3%
H
44.3
118.0
|
L
 54.9%
H
38.3
118.0
|
L
 319.5%
H
18.6
118.0
|
| LENSAR Inc |
|
70.6
|
5.8
|
L
 -0.9%
H
5.7
5.9
|
L
 -9.7%
H
5.7
6.4
|
L
 -18.7%
H
5.7
7.3
|
L
 -0.9%
H
5.0
9.3
|
L
 -51.5%
H
5.0
12.9
|
L
 113.0%
H
1.8
17.3
|
L
 -23.6%
H
1.8
17.3
|
L
H
1.8
17.3
|
| Lantheus Holdings Inc |
|
6,524.8
|
99.9
|
L
 0.2%
H
99.8
100.1
|
L
 -0.2%
H
99.6
100.4
|
L
 -0.6%
H
99.3
101.0
|
L
 -7.1%
H
98.8
109.5
|
L
 79.7%
H
50.2
111.9
|
L
 41.8%
H
47.3
126.9
|
L
 339.4%
H
22.5
126.9
|
L
 1055.1%
H
8.0
126.9
|
| Lucid Diagnostics Inc |
|
72.6
|
0.4
|
L
 -20.8%
H
0.4
0.5
|
L
 -40.6%
H
0.4
0.7
|
L
 -51.9%
H
0.4
0.9
|
L
 -60%
H
0.4
1.0
|
L
 -67.8%
H
0.4
1.6
|
L
 -68.9%
H
0.4
1.8
|
L
 -95.9%
H
0.4
11.1
|
L
H
0.4
13.5
|
| Pulmonx Corp |
|
75.2
|
1.8
|
L
 -1.7%
H
1.7
1.8
|
L
 -4.9%
H
1.7
1.9
|
L
 -15.5%
H
1.7
2.1
|
L
 25%
H
1.2
2.6
|
L
 15.1%
H
1.1
2.9
|
L
 -79.3%
H
1.1
14.8
|
L
 -95.5%
H
1.1
45.5
|
L
H
1.1
69.5
|
| 908 Devices Inc |
|
472.4
|
11.4
|
L
 1.5%
H
11.3
11.7
|
L
 -5.2%
H
11.2
12.2
|
L
 8.6%
H
10.5
13.4
|
L
 55.5%
H
6.9
13.4
|
L
 33.5%
H
5.0
13.4
|
L
 102.3%
H
1.8
13.4
|
L
 -64.8%
H
1.8
39.3
|
L
H
1.8
79.6
|
| Mimedx Grp Inc |
|
639.2
|
4.4
|
L
 -1.1%
H
4.3
4.5
|
L
 -6.2%
H
4.3
4.9
|
L
 -8.2%
H
4.3
5.0
|
L
 1.9%
H
3.8
5.0
|
L
 -34.5%
H
3.0
8.0
|
L
 -30.5%
H
3.0
10.1
|
L
 -36.9%
H
2.4
10.1
|
L
 -48.0%
H
1.0
18.3
|
| Mesa Laboratories Inc |
|
690.0
|
123.3
|
L
 0.7%
H
123.0
125.5
|
L
 -3.3%
H
122.2
129.7
|
L
 -2.6%
H
122.2
144.4
|
L
 25.9%
H
93.0
144.4
|
L
 68.7%
H
69.5
144.4
|
L
 23.3%
H
55.5
155.1
|
L
 -59.2%
H
55.5
333.4
|
L
 4.4%
H
55.5
333.4
|
| Merit Medical Systems Inc |
|
5,371.5
|
90.0
|
L
 0.9%
H
88.9
90.7
|
L
 3.2%
H
86.6
91.0
|
L
 5.4%
H
83.9
91.0
|
L
 21.6%
H
71.6
92.3
|
L
 9.9%
H
59.7
94.8
|
L
 36.3%
H
59.7
111.5
|
L
 30.0%
H
50.5
111.5
|
L
 276.4%
H
19.5
111.5
|
| Modular Medical Inc |
|
19.7
|
2.1
|
L
 -10.8%
H
2.1
2.4
|
L
 -23.9%
H
1.8
2.8
|
L
 -5.9%
H
1.8
3.1
|
L
 -30.5%
H
1.7
4.0
|
L
 -88.1%
H
1.7
18.8
|
L
 -93.5%
H
1.7
79.5
|
L
 -99.2%
H
1.7
450
|
L
 -91.5%
H
1.7
585.0
|
| MedTech Acq Corp (Class A) |
|
-
|
3.5
|
L
 -2.8%
H
3.5
3.7
|
L
 -13.1%
H
3.5
4.2
|
L
 -30.8%
H
3.5
5.8
|
L
 -17.7%
H
3.5
5.9
|
L
 -29.7%
H
2.2
8.0
|
L
 -31.3%
H
2.2
8.0
|
L
 -64.4%
H
2.2
12.8
|
L
H
2.2
12.8
|
| Myriad Genetics Inc |
|
402.7
|
4.2
|
L
 5.8%
H
4.0
4.2
|
L
 -2.3%
H
4.0
4.4
|
L
 8.2%
H
3.8
4.8
|
L
 -31.9%
H
2.7
6.2
|
L
 -46.0%
H
2.7
8.5
|
L
 -72.0%
H
2.7
29.3
|
L
 -86.9%
H
2.7
32.9
|
L
 -78.9%
H
2.7
50.4
|
| MDxHealth SA (ADR) |
|
9.4
|
0.2
|
L
 -14.3%
H
0.2
0.2
|
L
 -69.5%
H
0.2
0.7
|
L
 -71.4%
H
0.2
0.7
|
L
 -57.1%
H
0.2
1.1
|
L
 -95.5%
H
0.2
5.3
|
L
 -93.1%
H
0.2
5.3
|
L
H
0.2
13.2
|
L
H
0.2
13.2
|
| ENDRA Life Sciences Inc |
|
7.1
|
4.8
|
L
 0.2%
H
4.7
5.0
|
L
 -13%
H
4.7
5.7
|
L
 -13.6%
H
4.7
6.7
|
L
 -4.8%
H
4.1
6.8
|
L
 -22.5%
H
3.0
7.0
|
L
 -90.8%
H
0.0
139.5
|
L
 -99.7%
H
0.0
1750
|
L
H
0.0
5880
|
| Neogen Corp |
|
2,538.9
|
11.6
|
L
 -1.5%
H
11.6
12.0
|
L
 -1.9%
H
11.5
12.5
|
L
 -10.5%
H
11.1
14.3
|
L
 13.2%
H
9.1
14.3
|
L
 97.8%
H
5.4
14.3
|
L
 -24.2%
H
3.9
20.9
|
L
 -71.7%
H
3.9
47.8
|
L
 -41.9%
H
3.9
48.9
|
| Nephros Inc |
|
40.0
|
3.7
|
L
 0.8%
H
3.5
3.8
|
L
 4.3%
H
3.3
3.8
|
L
 -14.6%
H
3.0
4.4
|
L
 -2.7%
H
3.0
4.9
|
L
 -24.7%
H
2.7
6.4
|
L
 97.8%
H
1.4
6.4
|
L
 -51.9%
H
0.9
8.2
|
L
 23.9%
H
0.9
11.7
|
| NeuroOne Medical Tech Corp |
|
9.1
|
1
|
L
 4.2%
H
1.0
1.0
|
L
 -10.7%
H
1.0
1.1
|
L
 -28.1%
H
1.0
1.4
|
L
 -57.3%
H
1.0
3.5
|
L
 -79.8%
H
1.0
6.1
|
L
 -82.6%
H
1.0
12
|
L
 -94.4%
H
1.0
19.1
|
L
H
1.0
180
|
| Nano X Imaging Ltd |
|
32.2
|
0.4
|
L
 -8.9%
H
0.4
0.5
|
L
 -24.1%
H
0.4
0.6
|
L
 -43.8%
H
0.4
0.8
|
L
 -63.4%
H
0.4
1.2
|
L
 -89.7%
H
0.4
4.7
|
L
 -93.0%
H
0.4
14.3
|
L
 -98.2%
H
0.4
28.6
|
L
H
0.4
94.8
|
| NeuroPace Inc |
|
438.3
|
12.8
|
L
 4.3%
H
12.2
12.8
|
L
 0.8%
H
12.1
13.3
|
L
 -10.6%
H
12.1
14.9
|
L
 -20.6%
H
12.1
16.4
|
L
 22.7%
H
9.2
19.6
|
L
 107.6%
H
5.5
19.6
|
L
 -18.1%
H
1.2
19.6
|
L
H
1.2
27.4
|
| InspireMD Inc |
|
20.6
|
0.4
|
L
 -4.4%
H
0.4
0.5
|
L
 -15.4%
H
0.4
0.6
|
L
 -42.9%
H
0.4
0.8
|
L
 -37.1%
H
0.4
1.0
|
L
 -81.0%
H
0.4
2.4
|
L
 -86.7%
H
0.4
3.8
|
L
 -89.9%
H
0.4
4.6
|
L
 -100.0%
H
0.4
115237.5
|
| Nortech Systems Inc |
|
28.6
|
10.0
|
L
 -2.8%
H
9.6
10.2
|
L
 -11.6%
H
9.6
11.4
|
L
 -14.9%
H
9.6
11.8
|
L
 -27.7%
H
9.6
15.7
|
L
 4.5%
H
6.5
18.0
|
L
 25.1%
H
6.5
19.2
|
L
 -5.5%
H
6.5
19.6
|
L
 167.5%
H
2.5
19.6
|
| Nutriband Inc |
|
72.9
|
6
|
L
 -3.5%
H
5.7
6.3
|
L
 -9.8%
H
5.7
6.8
|
L
 -26.2%
H
5.7
9.2
|
L
 92.9%
H
2.8
9.2
|
L
 -19.8%
H
2.8
9.2
|
L
 152.1%
H
1.5
11.8
|
L
 0.5%
H
1.5
11.8
|
L
H
0.9
43.5
|
| Nuwellis Inc |
|
1.8
|
0.6
|
L
 1.8%
H
0.5
0.6
|
L
 -18.8%
H
0.4
0.7
|
L
 -37.8%
H
0.4
0.9
|
L
 -80.4%
H
0.4
6.4
|
L
 -83.7%
H
0.1
6.4
|
L
 -100.0%
H
0.1
1837.5
|
L
 -100.0%
H
0.1
364560
|
L
 -100.0%
H
0.1
10000000000
|
| NovoCure Ltd |
|
1,733.9
|
14.9
|
L
 5.8%
H
14.1
15
|
L
 2.1%
H
13.8
15
|
L
 -10.8%
H
13.8
16.9
|
L
 -6.5%
H
13.8
21.5
|
L
 8.1%
H
9.8
21.5
|
L
 -2.4%
H
9.8
34.1
|
L
 -86.5%
H
9.8
124.4
|
L
 110.3%
H
6.0
232.8
|
| enVVeno Medical Corp |
|
5.3
|
7.7
|
L
 3.0%
H
7.5
8.2
|
L
 -12.1%
H
7.2
8.8
|
L
 -14.4%
H
7.2
9.6
|
L
 -28.8%
H
7.0
12.5
|
L
 -70.4%
H
7.0
27.5
|
L
 -95.8%
H
7.0
244.0
|
L
 -97.7%
H
7.0
353.7
|
L
H
7.0
4935
|
| Nexalin Tech Inc |
|
2.5
|
2.4
|
L
 0.4%
H
2.1
2.4
|
L
 -35.0%
H
2.1
3.8
|
L
 -51.8%
H
2.1
11.0
|
L
 -83.5%
H
2.1
15.5
|
L
 -94.8%
H
2.1
50.7
|
L
 -78.4%
H
2.1
134.7
|
L
H
2.1
134.7
|
L
H
2.1
134.7
|
| Nyxoah SA |
|
96.7
|
1.0
|
L
 -14.4%
H
0.9
1.0
|
L
 -30.2%
H
0.9
1.4
|
L
 -35.8%
H
0.9
1.7
|
L
 -39.5%
H
0.9
1.8
|
L
 -83.6%
H
0.9
6
|
L
 -84.9%
H
0.9
20
|
L
 -96.1%
H
0.9
29.3
|
L
H
0.9
37
|
| Orchestra BioMed Holdings Inc |
|
339.6
|
5.7
|
L
 3.7%
H
5.4
5.7
|
L
 -5.0%
H
5.4
6.0
|
L
 -7.1%
H
5.4
6.5
|
L
 53.5%
H
3.6
6.5
|
L
 70.2%
H
3.3
6.5
|
L
 8.7%
H
2.2
11.7
|
L
 -42.6%
H
2.2
23.4
|
L
H
2.2
23.4
|
| Orthofix Medical Inc |
|
390.6
|
9.6
|
L
 2.2%
H
9.3
9.7
|
L
 4.6%
H
9.0
9.8
|
L
 10.1%
H
8.6
9.9
|
L
 -17.2%
H
8.5
12.6
|
L
 -36.3%
H
8.5
17.0
|
L
 -21.4%
H
8.5
20.7
|
L
 -73.5%
H
8.5
38.8
|
L
 -75.7%
H
8.5
74.4
|
| Outset Medical Inc |
|
71.4
|
3.8
|
L
 -3.6%
H
3.8
4.2
|
L
 -6.2%
H
3.8
4.2
|
L
 20.6%
H
2.8
4.3
|
L
 -9.5%
H
2.8
5.3
|
L
 -71.3%
H
2.8
15.9
|
L
 -94.0%
H
0.5
95.6
|
L
 -99.5%
H
0.5
905.0
|
L
H
0.5
1004.4
|
| Organogenesis Holdings Inc (Class A) |
|
131.2
|
1.0
|
L
 2%
H
0.9
1.1
|
L
 -20.9%
H
0.9
1.3
|
L
 -28.2%
H
0.9
1.5
|
L
 -61.1%
H
0.9
2.7
|
L
 -74.8%
H
0.9
7.1
|
L
 -56.6%
H
0.9
7.1
|
L
 -90.6%
H
0.9
12.3
|
L
H
0.9
310.9
|
| Orasure Tech Inc |
|
253.8
|
3.7
|
L
 1.9%
H
3.6
3.7
|
L
 -5.6%
H
3.6
4
|
L
 3.4%
H
3.6
4.1
|
L
 -4.9%
H
3.1
4.2
|
L
 21.9%
H
2.1
4.6
|
L
 -34.1%
H
2.1
8.5
|
L
 -65.1%
H
2.1
11.5
|
L
 -52.9%
H
2.1
23.0
|
| Pacific Biosciences of California Inc |
|
571.9
|
1.8
|
L
 6.4%
H
1.7
1.9
|
L
 -21.0%
H
1.7
2.3
|
L
 34.3%
H
1.3
3.4
|
L
 27.8%
H
1.1
3.4
|
L
 12.2%
H
1.1
3.4
|
L
 -75.9%
H
0.9
10.7
|
L
 -92.4%
H
0.9
31.1
|
L
 -78.8%
H
0.9
53.7
|
| PAVmed Inc |
|
22.1
|
2.3
|
L
 -6.6%
H
2.2
2.5
|
L
 -19.4%
H
2.2
2.8
|
L
 -43.2%
H
2.2
4.3
|
L
 -62.0%
H
2.2
5.9
|
L
 -85.2%
H
2.2
28.4
|
L
 -98.4%
H
2.2
146.3
|
L
 -99.9%
H
2.2
2857.5
|
L
 -100.0%
H
2.2
5454
|
| Pro-Dex Inc (co) |
|
186.6
|
57.7
|
L
 -1.0%
H
56
58.8
|
L
 -7.7%
H
56
64.0
|
L
 -20.5%
H
56
74.2
|
L
 0.6%
H
53
77
|
L
 120.1%
H
25.3
77
|
L
 238.4%
H
15.7
77
|
L
 122.8%
H
12.4
77
|
L
 1168.1%
H
3.8
77
|
| Pulse Biosciences Inc |
|
3,391.4
|
47.6
|
L
 7.0%
H
44.6
48.1
|
L
 -11.6%
H
43.3
54.0
|
L
 -11.7%
H
43.3
56.7
|
L
 65.8%
H
27.4
58.9
|
L
 170.8%
H
12.6
58.9
|
L
 1051.3%
H
3.8
58.9
|
L
 125.4%
H
1.2
58.9
|
L
 725.5%
H
1.2
58.9
|
| Axe Compute Inc |
|
93.8
|
8.1
|
L
 5.3%
H
7.9
8.4
|
L
 -30.7%
H
7.5
11.9
|
L
 -33.3%
H
7.5
13.5
|
L
 17.8%
H
6.6
13.5
|
L
 -15.2%
H
1.0
13.5
|
L
 -85.2%
H
1.0
60.3
|
L
 -97.7%
H
1.0
397.5
|
L
 -99.9%
H
1.0
18150
|
| Precision Optics Corp Inc |
|
46.9
|
4.3
|
L
 -1.2%
H
4.3
4.3
|
L
 -6.8%
H
4.3
4.7
|
L
 -4.3%
H
4.0
4.9
|
L
 -1.6%
H
4.0
5.0
|
L
 0.2%
H
3.6
6.2
|
L
 -26.4%
H
3.5
6.9
|
L
H
3.5
7.9
|
L
H
3.5
7.9
|
| Insulet |
|
9,845.5
|
142.0
|
L
 0.6%
H
139.5
142.4
|
L
 4.9%
H
133.6
143.3
|
L
 1.0%
H
128.0
143.3
|
L
 -13.5%
H
126.4
172.9
|
L
 -55.4%
H
126.4
354.9
|
L
 -2.0%
H
126.4
354.9
|
L
 -51.4%
H
125.8
354.9
|
L
 257.4%
H
30.7
354.9
|
| Procept BioRobotics Corp |
|
1,047.0
|
18.3
|
L
 4.0%
H
17.5
18.3
|
L
 -0.7%
H
17.5
19.9
|
L
 -5.3%
H
16.7
19.9
|
L
 -4.9%
H
16.7
22.9
|
L
 -44.6%
H
16.7
38.1
|
L
 -35.1%
H
16.7
103.8
|
L
 -58.9%
H
15.4
103.8
|
L
H
15.4
103.8
|
| Profound Medical Corp |
|
214.1
|
5.9
|
L
 -2.5%
H
5.8
6.3
|
L
 -15.1%
H
5.8
7.4
|
L
H
5.6
7.4
|
L
 -14.5%
H
5.5
8.5
|
L
 6.0%
H
4.8
9.0
|
L
 -37.3%
H
3.8
11.7
|
L
 -59.2%
H
3.1
15.5
|
L
 -33.1%
H
0.0
29.0
|
| QuidelOrtho Corporation |
|
875.0
|
12.8
|
L
 -1.2%
H
12.7
13.5
|
L
 -4.9%
H
12.7
14.7
|
L
 20.2%
H
9.9
14.7
|
L
 -26.6%
H
9.9
18.0
|
L
 -54.6%
H
9.9
35.6
|
L
 -81.4%
H
9.9
75.9
|
L
 -90.0%
H
9.9
180.1
|
L
 -39.6%
H
9.9
306.7
|
| Quanterix Corp |
|
131.0
|
2.8
|
L
 -3.5%
H
2.7
2.9
|
L
 -15.6%
H
2.7
3.4
|
L
 -9.8%
H
2.7
4.0
|
L
 -28.2%
H
2.2
4.1
|
L
 -52.7%
H
2.2
8.8
|
L
 -86.0%
H
2.2
29.7
|
L
 -94.5%
H
2.2
60.9
|
L
H
2.2
92.6
|
| AVITA Medical Inc |
|
1,513.6
|
13.1
|
L
 0.8%
H
12.7
13.4
|
L
 -0.5%
H
12.7
13.7
|
L
 19.2%
H
10.6
13.7
|
L
 157.7%
H
4.2
13.7
|
L
 229.3%
H
3.2
13.7
|
L
 31.1%
H
3.2
18.9
|
L
 -22.9%
H
3.2
21.7
|
L
 46%
H
3.2
55.4
|
| Rosecliff Acq Corp I (Class A) |
|
-
|
1.5
|
L
 0.7%
H
1.5
1.5
|
L
 -7.9%
H
1.5
1.7
|
L
 -7.3%
H
1.5
1.8
|
L
 -9.0%
H
1.5
1.8
|
L
 -36.4%
H
1.2
3.0
|
L
 -41.3%
H
1.2
4.7
|
L
 -84.4%
H
1.2
19.5
|
L
H
1.2
19.5
|
| Rockwell Medical Inc |
|
30.2
|
7.5
|
L
 0.8%
H
7.4
7.7
|
L
 -5.1%
H
7.2
8.2
|
L
 -7.1%
H
7.2
8.9
|
L
 22.4%
H
6.1
8.9
|
L
 -36.0%
H
4.9
12.9
|
L
 -58.0%
H
4.9
51.5
|
L
 -87.9%
H
4.9
71.5
|
L
 -98.8%
H
4.9
987.8
|
| Vyome Holdings Inc |
|
12.9
|
1.8
|
L
 -1.6%
H
1.8
1.9
|
L
 -12.0%
H
1.8
2.1
|
L
 -12.4%
H
1.8
2.1
|
L
 -14.4%
H
1.8
2.4
|
L
 -65.2%
H
1.8
6.6
|
L
 -89.2%
H
0.3
34.2
|
L
 -100.0%
H
0.3
9280
|
L
 -100.0%
H
0.3
1267590
|
| Rewalk Robotics Ltd |
|
356.5
|
5.9
|
L
 -1.2%
H
5.9
6.2
|
L
 -8.6%
H
5.9
6.5
|
L
 -14.3%
H
5.2
7.2
|
L
 -25.0%
H
5.2
8
|
L
 759.4%
H
0.4
9.6
|
L
 22.8%
H
0.4
9.6
|
L
 -39.1%
H
0.4
13.7
|
L
 -99.4%
H
0.4
1006.3
|
| Sight Sciences Inc |
|
455.0
|
8.3
|
L
 -0.2%
H
8.2
8.4
|
L
 -7.1%
H
8.2
9.0
|
L
 3.0%
H
7.8
9.7
|
L
 64.2%
H
4.4
9.7
|
L
 76.1%
H
3.4
9.7
|
L
 119.1%
H
1.0
9.7
|
L
 -62.6%
H
1.0
27.7
|
L
H
1.0
42.6
|
| Sotera Health Co |
|
5,034.0
|
17.6
|
L
 -1.4%
H
17.6
18.1
|
L
 -2.3%
H
17.6
18.5
|
L
 -5.8%
H
17.5
19.0
|
L
 -0.6%
H
16.8
19.8
|
L
 9.2%
H
13.1
19.9
|
L
 27.4%
H
9.5
19.9
|
L
 -32.1%
H
5.8
27.4
|
L
H
5.8
30.4
|
| SI-BONE Inc |
|
881.1
|
19.7
|
L
 -0.1%
H
19.4
19.9
|
L
 1.5%
H
19.2
20.3
|
L
 8.7%
H
17.8
20.3
|
L
 13.1%
H
16.3
20.3
|
L
 33.4%
H
11.5
21.9
|
L
 12.9%
H
11.5
21.9
|
L
 -9.4%
H
11.1
29.5
|
L
H
7.2
37.2
|
| SINTX Tech Inc |
|
12.8
|
1.7
|
L
 -2.3%
H
1.7
1.7
|
L
 -19.4%
H
1.7
2.2
|
L
 -1.7%
H
1.7
2.4
|
L
 6.9%
H
1.4
2.4
|
L
 -57.1%
H
1.4
4.5
|
L
 -98.6%
H
0.1
124
|
L
 -100.0%
H
0.1
26200
|
L
 -100.0%
H
0.1
7848000
|
| Beauty Health Co (Class A) |
|
68.6
|
10.6
|
L
 -0.1%
H
9.9
11.0
|
L
 -4.1%
H
9.9
12.9
|
L
 -21.9%
H
9.9
14
|
L
 -37.5%
H
9.9
17.4
|
L
 -63.1%
H
9.9
34.8
|
L
 -89.2%
H
9.9
103.4
|
L
 -98.0%
H
9.9
603.5
|
L
H
9.9
603.5
|
| Sanara MedTech Inc |
|
304.5
|
33.1
|
L
 -0.1%
H
32.8
33.3
|
L
 -5.5%
H
30.4
35.5
|
L
 -5.5%
H
30.4
35.5
|
L
 32.6%
H
24.8
35.5
|
L
 17.3%
H
16.1
35.5
|
L
 12.9%
H
16.1
43.3
|
L
 -0.6%
H
16.1
50.2
|
L
 564.1%
H
2
75
|
| Sensus Healthcare Inc |
|
45.4
|
2.8
|
L
 -0.4%
H
2.7
2.9
|
L
 -6.4%
H
2.7
3
|
L
 -9.5%
H
2.7
3.1
|
L
 -8.6%
H
2.7
3.7
|
L
 -13.8%
H
2.7
5.5
|
L
 12.7%
H
1.8
9.3
|
L
 -31%
H
1.8
15.3
|
L
 -54.5%
H
1.8
15.3
|
| Staar Surgical Co. |
|
1,097.2
|
21.9
|
L
 2.9%
H
21.2
22.0
|
L
 1.0%
H
21.1
22.4
|
L
 5.1%
H
19.1
23.0
|
L
 -17.3%
H
19.1
26.4
|
L
 -12.6%
H
15.6
35.9
|
L
 -48.6%
H
13.5
52.7
|
L
 -81.4%
H
13.5
128.3
|
L
 131.5%
H
7.5
163.1
|
| Neuronetics Inc |
|
145.5
|
1.9
|
L
 1.6%
H
1.9
1.9
|
L
 -10.3%
H
1.8
2.1
|
L
 -34.1%
H
1.8
3.0
|
L
 17.9%
H
1.7
3.4
|
L
 -29%
H
0.8
3.4
|
L
 69.0%
H
0.5
5.9
|
L
 -62.1%
H
0.5
7.0
|
L
H
0.5
39.4
|
| SkyAI Inc |
|
120.7
|
2.8
|
L
 5.3%
H
2.7
2.8
|
L
 53.3%
H
2.3
2.8
|
L
 64.1%
H
1.6
2.8
|
L
 140.5%
H
1.0
2.8
|
L
 -40.9%
H
0.9
5.5
|
L
 -99.9%
H
0.0
5446.3
|
L
H
0.0
23892
|
L
H
0.0
23892
|
| Tactile Systems Tech Inc |
|
514.9
|
22.7
|
L
 0.9%
H
22.5
22.8
|
L
 1.3%
H
22.0
23.4
|
L
 2.4%
H
21.6
23.4
|
L
 -20.9%
H
21.3
30.4
|
L
 56.4%
H
14.5
37.8
|
L
 106.3%
H
8.6
37.8
|
L
 -33.3%
H
6.3
38.8
|
L
 19.4%
H
6.3
76.6
|
| TELA Bio Inc |
|
43.8
|
1.0
|
L
 -1.0%
H
0.9
1.0
|
L
 -12.6%
H
0.9
1.2
|
L
 -22.4%
H
0.9
1.5
|
L
 32.9%
H
0.6
1.5
|
L
 -36.6%
H
0.5
1.6
|
L
 -83.4%
H
0.5
7.8
|
L
 -92.4%
H
0.5
14
|
L
H
0.5
23.5
|
| Valion Bio Inc |
|
2.3
|
1.2
|
L
 -0.9%
H
1.0
1.2
|
L
 -45.8%
H
1.0
2.1
|
L
 -45.3%
H
1.0
4.4
|
L
 -90.8%
H
1.0
32.5
|
L
 -98.4%
H
1.0
74.5
|
L
 -99.8%
H
1.0
1364.2
|
L
H
1.0
276250
|
L
H
1.0
276250
|
| Treace Medical Concepts Inc |
|
252.3
|
3.9
|
L
 0.3%
H
3.8
4.0
|
L
 -1.8%
H
3.8
4.2
|
L
 -13.6%
H
3.8
4.7
|
L
 -9.8%
H
3.8
5.2
|
L
 -39.8%
H
1.2
7.1
|
L
 -60.8%
H
1.2
16.0
|
L
 -84.2%
H
1.2
28.0
|
L
H
1.2
37.2
|
| Transmedics Grp Inc |
|
2,482.7
|
71.6
|
L
 1.2%
H
70.5
72.8
|
L
 -8.1%
H
70.0
80.4
|
L
 -17.2%
H
70.0
89.8
|
L
 -3.2%
H
68
95.2
|
L
 -39.1%
H
60.1
156
|
L
 69.7%
H
36.4
177.4
|
L
 171.9%
H
10
177.4
|
L
H
10
177.4
|
| Tandem Diabetes Care Inc |
|
1,139.7
|
16.4
|
L
 0.9%
H
16
16.5
|
L
 1.7%
H
15.6
17.3
|
L
 -2.9%
H
14.8
18.0
|
L
 -4.1%
H
14.8
24.8
|
L
 10.8%
H
12.3
29.7
|
L
 -14.5%
H
10.0
53.7
|
L
 -86.7%
H
10.0
155.9
|
L
 -75.2%
H
2.1
155.9
|
| Trinity Biotech PLC (ADR) |
|
6.7
|
8.2
|
L
 2.0%
H
7.6
8.8
|
L
 19.4%
H
6.2
8.8
|
L
 13.3%
H
5.0
8.8
|
L
 -18.8%
H
5.0
14.2
|
L
 -72.4%
H
5.0
52.5
|
L
 -99.9%
H
5.0
12562.5
|
L
 -100.0%
H
5.0
40500
|
L
 -100.0%
H
5.0
138750
|
| Utah Medical Products Inc |
|
236.6
|
74.6
|
L
 0.1%
H
74.5
74.9
|
L
 0.0%
H
73.9
75.3
|
L
 0.8%
H
73.2
76.9
|
L
 6.8%
H
63.8
76.9
|
L
 25.4%
H
53.7
76.9
|
L
 -10.4%
H
51.3
87.3
|
L
 -16.3%
H
51.3
133.9
|
L
 20.9%
H
51.3
133.9
|
| Vivani Medical Inc |
|
101.0
|
1.1
|
L
H
1.1
1.1
|
L
 -10.4%
H
1.1
1.2
|
L
 -5.9%
H
1.1
1.3
|
L
 -15.2%
H
1.1
1.5
|
L
 -33.7%
H
0.9
1.9
|
L
 9.8%
H
0.8
7.8
|
L
 -87.0%
H
0.8
10.3
|
L
 -98.3%
H
0.8
84.2
|
| Veracyte Inc |
|
3,521.1
|
43.8
|
L
 1.6%
H
43.4
45.0
|
L
 -3.2%
H
42.2
45.8
|
L
 10.1%
H
39.4
49
|
L
 -25.9%
H
38.2
60.0
|
L
 22.2%
H
29.5
60.9
|
L
 111.1%
H
18.6
60.9
|
L
 -3.0%
H
14.9
60.9
|
L
 465.2%
H
5.2
86.0
|
| Varex Imaging Corp |
|
781.3
|
18.4
|
L
 -0.1%
H
18.4
18.4
|
L
 -0.3%
H
18.4
18.5
|
L
 -0.5%
H
18.4
18.5
|
L
 74.4%
H
10.4
18.6
|
L
 59.6%
H
9.1
18.6
|
L
 2.3%
H
6.8
21.5
|
L
 -30.7%
H
6.8
32.7
|
L
H
6.8
43.8
|
| Vivos Therapeutics Inc |
|
2.8
|
0.1
|
L
 7.7%
H
0.1
0.1
|
L
 -6.7%
H
0.1
0.2
|
L
 -12.5%
H
0.1
0.2
|
L
 -66.7%
H
0.1
0.5
|
L
 -95.2%
H
0.1
3.1
|
L
 -98%
H
0.1
48.8
|
L
 -99.9%
H
0.1
106.8
|
L
H
0.1
360.3
|
| Wrap Tech Inc |
|
80.9
|
1.3
|
L
 3.2%
H
1.3
1.3
|
L
 -7.8%
H
1.2
1.4
|
L
 -13.8%
H
1.2
1.6
|
L
 -36.1%
H
1.2
2.1
|
L
 -42.0%
H
1.0
3.2
|
L
 -7.7%
H
1.0
7.0
|
L
 -77.3%
H
1.0
7.0
|
L
H
1.0
14.4
|
| Beyond Air Inc |
|
2.1
|
2.1
|
L
 -0.9%
H
2.1
2.2
|
L
 -4.9%
H
2.1
2.5
|
L
 -30.7%
H
2.1
3.2
|
L
 -61.7%
H
2.1
7.7
|
L
 -95.5%
H
2.1
53.2
|
L
 -99.8%
H
2.1
1044
|
L
 -99.9%
H
2.1
6564
|
L
 -100.0%
H
2.1
6564
|
| DENTSPLY Sirona Inc |
|
1,678.6
|
8.4
|
L
 -1.8%
H
8.3
8.6
|
L
 -4.6%
H
8.3
8.9
|
L
 -11.7%
H
8.3
10.0
|
L
 -40.1%
H
8.3
14.4
|
L
 -32.7%
H
8.3
14.8
|
L
 -74.0%
H
8.3
37.6
|
L
 -85.0%
H
8.3
59.5
|
L
 -85.7%
H
8.3
69.5
|
| X.T.L. Biopharma Ltd (ADR) |
|
4.8
|
2.0
|
L
H
1.9
2.0
|
L
 -1.0%
H
1.9
2.0
|
L
 -18.3%
H
1.9
2.5
|
L
 -31.0%
H
1.9
3.5
|
L
 -90.3%
H
1.9
22.1
|
L
 -87.5%
H
1.9
79.8
|
L
 -96.9%
H
1.9
79.8
|
L
 -97.4%
H
1.9
107.0
|
| 111 Inc (ADR) |
|
27.6
|
3.1
|
L
 0.3%
H
3.1
3.1
|
L
 -0.3%
H
3.0
3.3
|
L
 -12.8%
H
3.0
4.1
|
L
 -13.5%
H
2.7
4.1
|
L
 -26.3%
H
2.5
11.2
|
L
 31.9%
H
0.4
11.3
|
L
 -43.7%
H
0.4
11.3
|
L
H
0.4
45.9
|
| Jin Medical Intl Ltd |
|
325.8
|
2.1
|
L
 1.4%
H
2.0
2.1
|
L
 2.4%
H
2.0
2.2
|
L
 6.0%
H
1.9
2.2
|
L
 11.1%
H
1.5
3.7
|
L
 -67.9%
H
1.5
8.5
|
L
 -88.9%
H
1.5
509.9
|
L
H
1.5
509.9
|
L
H
1.5
509.9
|
| HeartBeam Inc |
|
23.1
|
0.4
|
L
 -6.8%
H
0.4
0.4
|
L
 -14.6%
H
0.4
0.5
|
L
 2.5%
H
0.4
1.0
|
L
 -26.8%
H
0.4
1.0
|
L
 -76.0%
H
0.4
4
|
L
 -74.1%
H
0.4
4
|
L
 -74.1%
H
0.4
4
|
L
 -74.1%
H
0.4
4
|
| TriSalus Life Sciences Inc |
|
217.4
|
3.5
|
L
 -2.8%
H
3.5
3.7
|
L
 -13.1%
H
3.5
4.2
|
L
 -30.8%
H
3.5
5.8
|
L
 -17.7%
H
3.5
5.9
|
L
 -29.7%
H
2.2
8.0
|
L
 -28.0%
H
2.2
10.4
|
L
 -47.9%
H
2.2
10.4
|
L
 -47.9%
H
2.2
10.4
|
| Cencora |
|
64,881.2
|
340
|
L
 -0.3%
H
336.5
342.2
|
L
 5.0%
H
323.6
345.5
|
L
 10.1%
H
295.0
345.5
|
L
 10.4%
H
295.0
345.5
|
L
 4.7%
H
244.8
377.5
|
L
 79.4%
H
182.8
377.5
|
L
 187.2%
H
113.7
377.5
|
L
 319.3%
H
68.4
377.5
|
| Spectral AI Inc (Class A) |
|
48.9
|
1.5
|
L
 0.7%
H
1.5
1.5
|
L
 -7.9%
H
1.5
1.7
|
L
 -7.3%
H
1.5
1.8
|
L
 -9.0%
H
1.5
1.8
|
L
 -36.4%
H
1.2
3.0
|
L
 -41.3%
H
0.8
4.7
|
L
H
0.8
13
|
L
H
0.8
13
|
| Envoy Medical Inc (Class A) |
|
50.3
|
0.7
|
L
 -3.0%
H
0.6
0.7
|
L
 -1.5%
H
0.6
0.7
|
L
 -8.5%
H
0.6
0.7
|
L
 -7.1%
H
0.6
0.8
|
L
 -22.6%
H
0.4
1.0
|
L
 -68.0%
H
0.4
11.5
|
L
H
0.4
11.5
|
L
H
0.4
11.5
|
| Autonomix Medical Inc |
|
5.2
|
2.7
|
L
 -6.7%
H
2.6
2.9
|
L
 -14.8%
H
2.6
3.2
|
L
 -37.1%
H
2.6
4.3
|
L
 -40.5%
H
2.4
24.7
|
L
 -88.8%
H
2.4
32.6
|
L
H
2.4
3192
|
L
H
2.4
3192
|
L
H
2.4
3192
|
| Rewalk Robotics Ltd |
|
16.8
|
5.9
|
L
 -1.2%
H
5.9
6.2
|
L
 -8.6%
H
5.9
6.5
|
L
 -14.3%
H
5.2
7.2
|
L
 -25.0%
H
5.2
8
|
L
 -28.3%
H
4.1
9.6
|
L
 -89.8%
H
4.1
109.2
|
L
 -94.9%
H
4.1
163.8
|
L
 -100.0%
H
4.1
12075
|
| GRAIL Inc |
|
5,468.0
|
122.4
|
L
 3.9%
H
117.6
124.5
|
L
 -12.9%
H
117.1
144.2
|
L
 51.6%
H
92
166.5
|
L
 68.6%
H
60.8
166.5
|
L
 57.0%
H
41.5
166.5
|
L
H
12.6
166.5
|
L
H
12.6
166.5
|
L
H
12.6
166.5
|
| Work Medical Tech Grp Ltd |
|
5.4
|
1.2
|
L
 10.1%
H
1.1
1.2
|
L
 -21.6%
H
1.0
1.5
|
L
 -37.2%
H
1.0
2.0
|
L
 -39.7%
H
1.0
3.2
|
L
 -100%
H
1.0
83600
|
L
H
1.0
8446000
|
L
H
1.0
8446000
|
L
H
1.0
8446000
|
| iTonic Holdings Ordinary |
|
63.3
|
3.7
|
L
 -3.4%
H
3.6
4.0
|
L
 -8.6%
H
3.5
4.3
|
L
 1059.4%
H
0.2
4.5
|
L
 1225%
H
0.2
4.5
|
L
 488.9%
H
0.2
4.5
|
L
H
0.2
32
|
L
H
0.2
32
|
L
H
0.2
32
|
| Ceribell Inc |
|
997.8
|
26
|
L
 3.8%
H
24.6
26.5
|
L
 10.0%
H
23.3
27.9
|
L
 6.7%
H
22.6
27.9
|
L
 38.9%
H
16.0
27.9
|
L
 104.6%
H
10.9
27.9
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
| Anteris Tech Global Corp |
|
602.3
|
6.2
|
L
 2.2%
H
6.1
6.3
|
L
 -8.7%
H
6.0
6.8
|
L
 -24.3%
H
6.0
8.3
|
L
 -26.9%
H
6.0
10.1
|
L
 26.9%
H
3.3
11.1
|
L
H
2.3
11.1
|
L
H
2.3
11.1
|
L
H
2.3
11.1
|
| Beta Bionics Inc |
|
908.5
|
16.8
|
L
 3%
H
16.6
17.4
|
L
 -4.5%
H
16.3
18.6
|
L
 -23.1%
H
16.3
23.6
|
L
 -2.6%
H
12.7
23.6
|
L
 -15.9%
H
8.8
32.7
|
L
H
8.8
32.7
|
L
H
8.8
32.7
|
L
H
8.8
32.7
|
| DataMEDS AI Inc |
|
12.1
|
2.7
|
L
 1.5%
H
2.6
3.1
|
L
 -9.8%
H
2.6
3.8
|
L
 -29.0%
H
2.6
5.4
|
L
 0.8%
H
0.8
12.3
|
L
 -88.9%
H
0.8
73
|
L
H
0.8
352
|
L
H
0.8
352
|
L
H
0.8
352
|
| Anbio biotech (Class A) |
|
143.5
|
3.3
|
L
 4.5%
H
3.2
3.5
|
L
 -29.8%
H
3.1
4.7
|
L
 -37.7%
H
3.1
7.0
|
L
 -65.5%
H
3.1
13.8
|
L
 -88.7%
H
3.1
44.7
|
L
H
3.1
55.7
|
L
H
3.1
55.7
|
L
H
3.1
55.7
|
| Kestra Medical Tech Ltd |
|
1,749.3
|
29.4
|
L
 7.8%
H
27.0
29.8
|
L
 8.9%
H
25.4
29.8
|
L
 20.2%
H
24.1
29.8
|
L
 20.3%
H
20.4
29.8
|
L
 19.3%
H
17.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
L
H
13.3
30
|
| Sanuwave Health Inc |
|
41.5
|
4.8
|
L
 -2.6%
H
4.8
5.1
|
L
 -14.1%
H
4.8
6.0
|
L
 6.2%
H
4.2
6.0
|
L
 -24.4%
H
3.9
6.7
|
L
 -85.8%
H
3.9
36.2
|
L
 -85.1%
H
3.9
46.6
|
L
 -85.1%
H
3.9
46.6
|
L
 -85.1%
H
3.9
46.6
|
| SS Innovations Intl Inc |
|
490
|
2.5
|
L
 -3.2%
H
2.3
2.6
|
L
 -7.2%
H
2.3
2.8
|
L
 -24.9%
H
2.3
3.4
|
L
 -32.7%
H
2.3
4.2
|
L
 -74.9%
H
2.3
10
|
L
H
2.3
22.4
|
L
H
2.3
22.4
|
L
H
2.3
22.4
|
| CapsoVision Inc |
|
354.9
|
6.7
|
L
 2.1%
H
6.5
6.7
|
L
 1.2%
H
6.2
6.8
|
L
 -0.5%
H
5.9
7.0
|
L
 -0.6%
H
5.8
7.3
|
L
 37.8%
H
4.5
15.4
|
L
 90.6%
H
3.4
15.4
|
L
 90.6%
H
3.4
15.4
|
L
 90.6%
H
3.4
15.4
|
| Pomdoctor ADR |
|
4.9
|
0.5
|
L
 -15.9%
H
0.5
0.8
|
L
 -31.2%
H
0.5
0.8
|
L
 -33.8%
H
0.5
1.1
|
L
 -53.1%
H
0.5
1.2
|
L
 -99.3%
H
0.5
115.7
|
L
 -99.3%
H
0.5
115.7
|
L
 -99.3%
H
0.5
115.7
|
L
 -99.3%
H
0.5
115.7
|
| Medline Inc Ordinary Shares |
|
30,874.0
|
35.2
|
L
 -2.1%
H
35
36.4
|
L
 -3.0%
H
34.9
37.0
|
L
 11.2%
H
31.6
37.0
|
L
 -11.6%
H
31.5
42.2
|
L
 -14.2%
H
31.5
50.9
|
L
 -14.2%
H
31.5
50.9
|
L
 -14.2%
H
31.5
50.9
|
L
 -14.2%
H
31.5
50.9
|
| MiniMed Group Inc |
|
5,005.2
|
17.8
|
L
 1.7%
H
17.2
18.1
|
L
 -9.7%
H
16.6
19.5
|
L
 -18.4%
H
16.6
22.3
|
L
 5.1%
H
16.0
24.4
|
L
H
10.7
24.4
|
L
H
10.7
24.4
|
L
H
10.7
24.4
|
L
H
10.7
24.4
|
| Mobia Medical Inc |
|
293.3
|
8.8
|
L
 8.9%
H
8.0
8.9
|
L
 2.1%
H
8.0
8.9
|
L
 -16.4%
H
8.0
10.7
|
L
 -27.5%
H
8.0
13.9
|
L
 -25.0%
H
8.0
15.3
|
L
 -25.0%
H
8.0
15.3
|
L
 -25.0%
H
8.0
15.3
|
L
 -25.0%
H
8.0
15.3
|
| FocalTherics ADR |
|
192.2
|
4.1
|
L
 -0.5%
H
4.1
4.2
|
L
 -2.9%
H
4.0
4.4
|
L
 -1.9%
H
4.0
4.8
|
L
 -25.2%
H
4.0
6.4
|
L
 -10.8%
H
4.0
6.4
|
L
 -10.7%
H
4.0
6.4
|
L
 -10.7%
H
4.0
6.4
|
L
 -10.7%
H
4.0
6.4
|